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Abstract: Cancer is a malignant abnormal growth of cells, one of the most 
dreaded and complex diseases. It concerns with several tempo spatial changes 
in cell composition, which finally lead to neoplasia. Various types of cancers 
have been reported. Chemotherapy, radiation, and/or surgery may cure them. 
Herbal remedies are supposed to be harmless as they cause fewer complications 
and are less likely to habitual. Antioxidant compositions of therapeutic plants 
show the anticancer activity and therefore, use of different proportions of the 
active components to formulate various standardized preparation with single 
or multiple components for their synergistic effects play a crucial role in curing 
cancer. Evaluation parameters to assess the in vitro anticancer activity includes 
Caspase-3, Caspase-9, alamar blue, LDH assay, XTT assay, sulforhodamine-B 
assay, MTT assay, DNA fragmentation assay, neutral red uptake cytotoxic 
assay,  tryphan blue assay. Evaluation of dried extract or granules includes 
bulk density, tapped density, Carr’s index, Hausner’s ratio, angle of repose 
while the tablets evaluated by drug-excipient compatibility study by FT-IR, 
stability studies, hardness, thickness, weight variation, friability, disintegration 
time and dissolution test.
1. INTRODUCTION
Malignancy persists to distinguish the leading cause of death in the human 
race and claims greater than 6 million lives per year (Abdullaev, 2001). An 
extremely potential approach to prevent cancer is chemotherapy, which 






or in combinations to obstruct the development of tumor in people. Plants, 
vegetables and herbs used in the folk and conventional pharmaceuticals have 
been acknowledged right now as one of the main wellspring of malignancy 
chemoprevention drug discovery and advancement (Abdullaev, 2000).  
Therapeutic plants have been utilized as medicine for individual diseases 
for a long time. The rationale behind utilizing them as a drug lies in the 
fact that they have chemical compositions of medicinal values (Nostro A 
et al, 2000).  The therapeutic importance of plants lays in some chemical 
components usually derivative metabolites that take them into being a specific 
physiological accomplishment on the human being. Mainly the alkaloids, 
flavanoids, tannins and phenolic compounds are important biologically active 
metabolites responsible for the therapeutic significance (Edeoga HO et al. 
2005).
Since1950, the search for anticancer agents from plants origin started 
and leads to recognition and isolation of the vinca alkaloids, vincristine 
and vinblastin, the separation of the cytotoxic principles podophyllotoxins 
(Pezzuto JM, 1997; Reddy L  et al.2003). Over 60% of presently utilized 
anticancer agents are obtained from natural sources (Cragg GM and Newman 
DJ, 2003; Balunas MJ and Kinghorn AD, 2005). Some plants that have been 
assessed and showed prominent antineoplastic potential are Glucyrrhiza 
glabra, Cinnamomum tamala, Ocimum sanctum, Madhuca longifolia, Emblica 
officinalis, Adina cordifolia, Aloe barbadensis, Sida Veronicaefolia, Zingiber 
Officinalis, Terminalia arjuna, Citrus medica, Catharanthus roseus, Nicotiana 
tabacum, Alium cepa, Allium sativam, Curcuma longa etc. Biologically active 
metabolites from plants are important source of novel drugs that are likely to 
lead to development in treatments of variety of cancers. Beside cancer cells, 
the normal cells are also been destroyed by chemotherapy, and sometimes 
mutations leads to resistance development in the cancer cells (Wiseman LR 
and Spencer CM, 1998).Therefore, before the forests are lost to deforestation, 
screening for the wealth of biodiverse components is imperative for research. 
The formulation prepared by plant extracts or complete plant material 
with appropriate excipients are known as Herbal formulations. These extracts 
are composed of active constituent, thus with appropriate excipients or base, 
various formulations are formulated and standardized with suitable technique. 
formulations with two or more herbs, are known as polyherbal formulations.
To clear the mechanisms in anticancer actions of herbs, it is strongly 
suggested to get more cellular and molecular studies. For this, various in 
vitro and in vivo methods have been developed to determine the effectiveness 
of natural anticancer compounds. In vitro methods like, tryphan blue dye 






and Sulforhodamine B assay and many more are most commonly used for 
estimating anticancer properties of natural products from medicinal plants. 
Dried extract evaluation include determination of Bulk density, Tapped 
density, Carr’s index, Hausner’s ratio, Angle of repose while the tablets 
evaluated by Drug-Excipient Compatibility Study by FT-IR, Stability studies, 
Hardness, Thickness, Weight Variation, Friability, Disintegration Time, In 
vitro Dissolution test.
2. EVALUATION PARAMETERS 
2.1 In- vitro Evaluation Parameters
2.1.1 Caspase-3 
A Cysteine-dependent aspartate-directed proteases known to be Caspases are a 
class of proteases that cause cell death. A part of the CED-3 subfamily of caspase 
i.e. Caspase-3 is one of the significant enzymes of apoptosis. Procaspase 2, 6, 
7 and 9 processed by Caspase-3, purposely cleaves largely of caspase related 
substrates, which is a part of the mechanism leading to cell death. The proteins 
that regulate apoptosis and are inhibitor of caspase-activated deoxyribonuclase 
gelsolin and fodrin are nuclear enzyme activate poly (ADP-ribose), and 
polymerase (PARP) (Sakahira H et al, 1998 and Nicholson DW et al, 1995). 
Mediating nuclear apoptosis, chromatin condensation or DNA fragmentation 
and cell blebbing, Caspase-3 plays an important role. Its activity in cells and 
tissues of the body is a sign of cell death (Porter AG and Janicke RU, 1999).
The mechanism of Caspase-3 colorimetric assay is depend upon the 
hydrolysis of the peptide substrate acetyl-Asp-Glu-Val-Asp p-nitroanilide 
by Caspase-3 and leads to release in p-nitroanilide moiety having a high 
absorbance at 405 nm (ΣmM = 10.5). From the absorbance values at 405 nm, 
concentration of p-nitroanilide released from the substrate is determined.
 Ac-DEVD pNA Ac-DEVD pNACaspase−  → +−3  
The Caspase-3 activation is in apoptosis process (Thornberry NA and 
Littlewood Y 1998; Wolf BB et al, 1999).
2.1.2 Caspase-9
Caspase-9 also known as initiater caspase, a proenzyme that brings cellular 
apoptosis (Duan H et al, 1996). Caspase-9 become activated at the time of 
release of mitochondrial cytochrome-c and follows its association with the 
protein complex of Apaf and cytochrome-c. By protein phosphoylation, active 






Asp-7 (LEHD). Association of caspase-9 with pro-apoptotic, anti-apoptotic 
proteins and its regulatory function during embryonic development proves that 
it is a key regulatory enzyme of apoptosis (Petty RD, 1995; Thornberry NA et 
al, 1997). The measurement of caspase-9 activity is possible by a homogenous 
luminescent assay kit known as Caspase-Glo® 9. Cell lysis caused by addition 
of Caspase-Glo®-9 reagents followed by caspase cleavage of the substrate 
and luciferase reaction that produce luminescent signals that is equivalent to 
amount of caspase activity present, shows in Figure 1.
Figure 1: Caspase-9 cleavage of the luminogenic substrate containing 
the LEHD sequence.
2.1.3 Alamar Blue Resazurin Reduction Assay
A suspension of Cell in 100 μl of DMEM (Dulbecco’s Modified Eagle’s 
Medium)  were prepared and seeded in 96-well plates upto the density of 5 × 
103 cells per well following by incubation for 24 h. A supplemented media were 
used to dilute the different extracts using a separate 96-well plate followed by 
incubation for 48 h after which addition of 100 μl of fresh media, (containing 
10%  v/v of a 860 μM solution of resazurin in Phosphate Buffer Saline) to the 
cells, and incubated for 2 to 4 h.  A SpectraMax M5 plate was then employed 






nm. By the help of an exponential decay curve fit and fluorescence intensity 
values, IC50 values were calculated. A negative control i.e. DMSO and a a 
positive control i.e. Nile Blue-A were used (Lin CW et al, 1991).
2.1.4 LDH assay 
At the time of the pyruvate-lactate transformation, we can measure the activity 
of Lactic dehydrogenase in the culture medium and in the cellular lysates 
spectrophotometrically at 340 nm by analyzing NADH reduction. Break down 
of cell membrane was done by the addition of a mixture containing 50 mM 
Tris-HCl buffer of pH 7.4, 20 mM EDTA and 0.5 % Sodium Dodecyl Sulfate 
to the Cells, and then disrupted by sonication followed by 15 min centrifugion 
at 13,000 X g. 1ml of total final volume of assay mixture having 33 μl of 
sample in 48 mM PBS at pH 7.5, 1 mM pyruvate and 0.2 mM NADH was used 
for the enzymatic analysis. The percentage of the entire amount of enzymatic 
activity present in the cellular lysate and in the culture medium represent the 
percentage of LDH released (Russo A et al, 2006).
2.1.5 XTT assay
For quantification of viable cells, an assay was done by the use of tetrazolium 
salt (XTT) i.e.  (2,3-bis[2-Methoxy-4-nitro-5-sulfophenyl]- 2Htetrazolium- 
5-carboxyanilide. In this assay, mitochondrial enzyme dehydrogenase in living 
cells cleaved XTT into orange formazan dye and devoid of the employment 
of radioactive isotopes; spectrophotometric quantification of cell growth and 
viability was detetmined. 
In 96-well plates, cells are grown in growth medium containing 10 % FBS 
until 70-80 % confluence after that suitable drug sample treated these cells 
for 24 h. And finally, XTT assay is performed by addition of 50 mL of XTT 
labeling mixture solution to each well and the cells are incubated at 37 °C for 4 
h. With the help of a screening multiwell spectrophotometer reader, the control 
wells is compared with aqueous soluble formazan dye having the optical 
density at 450 nm by taking  650 nm reference wavelength using ELISA reader 
(Economou MA et al, 2008).
2.1.6 Sulforhodamine-B assay 
Assay is based on dissociation of Sulforhodamine B (a bright pink 
aminoxanthene dye) under basic condition and binds to basic amino acids in 
mild acidic conditions. Different cell numbers plated i.e. 5000-10000 \zcell/
well are available for adjusting differences in the growth rates of the various 






stick to the wells overnight, and then in serial 3-fold dilutions the samples are 
added to triplicate wells. Water is added to the control wells at a 1:10 dilution 
in medium and for 3 days at 37 °C and 5 % CO2 plates are incubated and by 
using a sulforhodamine B assay growth inhibition is determined. 
For fixation of cells, 10% volume of cold 50% trichloroacetic acid is added 
and incubated for 1 h at 4 °C, after that wash the cells with deionized water at 
least five times. Staining the cells for 15-30 min by the addition of 0.4 % SRB 
in 1 % acetic acid and then wash these cells five times with 1 % acetic acid to 
remove unbound stain. Dry these plates at room temperature and by using 10 
mm Tris base the bound dye is solubilised and analysing these plates at 595 nm 
on a microplate reader (Skehan P et al, 1990).
 %growth inhibition Controlsample
Control
= ×100  
2.1.7 MTT Assay 
It is a colorimetric assay to determine the metabolic activity of of viable 
cells. The enzymes cellular oxidoreductase occurs in metabolically active 
cells converts MTT, a yellow tetrazolium salt ([3- (4, 5-dimethylthiazol-
yl)-2, 5-diphenyltetrazolium bromide]) by into purple-formazan crystals, that 
reflecting number of viable cells. 
For plating the cells a 96 well plates at a cell density of 2×105 per mL per 
well in 100 μL of RPMI 1640 are used. For incubation of cells, CO2 incubator 
is used for 24 h at 37 ˚C and 5 % CO2 that allow cells to grow. After incubation 
medium is removed and a fresh medium with different sample concentrations 
is added for 48 h. Again these cells are incubated for 24-48 h at 37 ˚C and 5 % 
CO2.Then each well is treated with 20 μL MTT stock solution in PBS (5mg/
mL) and incubated for 5 h. To dissolve the MTT metabolic product, removing 
the medium and add 200 μL DMSO to each well and shake the plate at 150 
rpm for 5 min and measured the optical density is at 560nm. For control of 
viability (100 %), untreated cells (basal) are used and by using % viability 
(log) relative to the control, results are determined (Mossman T 1983).
2.1.8 DNA Fragmentation Assay
For this assay, 60mm Petri dishes were taken and HeLa cells (3 x 106 /ml) were 
seeded on it and allow incubating for 24 h at 37°C with 5% CO2. Then wash 
the cells with medium. Add extract and standard drug and incubate the cells 
for 24hrs at 37ºC, 5% CO2. After completion of incubation, use the apoptotic 






electrophoresis technique was use in which recovered DNA was loaded onto 
2% agarose. Running time was 3hrs for 50 V/cm. For gel visualization, UV 
transilluminator was used and photographed (Sirimal GK, 2015).  
2.1.9 Neutral Red Uptake Cytotoxic assay
To perform this assay, dissolve 3.3gm of Neutral Red dye in 100 ml of double 
distilled water and filter this stock solution by syringe filter and then stored it 
at room temperature. This stock solution was then better used within 6 months. 
Take 99 ml of culture media with 1 ml of Neutral Red stock solution and 
finally get 0.33%. Previously incubated Cell plates were taken and the culture 
media from the plates were removed and add the extract containing culture 
media. To get the appropriate action of extract, the plates were incubated for 
24 hrs in CO2 incubator. The Neutral Red containing medium replace the 
extract containing culture media and depending upon cell type, cells were 
again incubatefor 4-8 hours. After incubation, remove the medium cautiously 
and wash the cells immediately with PBS. Eliminate the washed solution and 
finally dye was solubilized by means of Neutral Red Assay Solubilization 
Solution i.e. ethanolic and acetic acid in the quantity equal to the original 
quantity of culture medium.
 Now at room temperature, keep the plates to stand for 10 minutes. To 
improve mixing of the solubilized dye, gyratory shaker was used. With ELISA 
reader, optical density of background absorbance was calculated at 540 nm 
and pictures were captured using microscope (Mosmann T, 1983). 
Calculation of % inhibition was done by using the formula 
 
%inhibition




2.1.10 Tryphan Blue assay
Assay is based on testing the cell viability leaving out by the trypan blue dye. 
Hank’s Buffered Salt Solution (HBSS) is used to wash the cells and centrifuged 
at 10,000 rpm for 10 -15 min. Repeat this procedure three times. Suspend the 
cells in known amount of HBSS and adjust the cell count to 2 x 106 cells /ml. 
Eppendorf tubes is taken to distribute the cell suspension. The cells are treated 
with drug dilutions and incubate for 3 h at 37 °C. After incubation, perform the 
dye exclusion test. In this test, same amount of the drug treated cells are mixed 






with above mixture to record viable and non-viable count within 2 min. Dye 
transverses into dead cells while viable cells do not absorb colour and remain 
colourless (Unnikrishnan MC and Ramadasan K, 1998).
Formula for calculating % growth inhibition is 
 Growth inhibition Totalcells-Deadcells
Totalcells
(%) = − ( ) ×100 100  
2.2 Evaluation of Dried Extract or Granules 
2.2.1 Bulk density (DB)
Lumps produced in the sample at the time of storage are finally broken up by 
passing the sample through sieve no. 18. Take a 100ml graduated cylinder and 
transfer the sample to it by avoiding any compacting. Take bulk volume (Vb) 
upto the nearest unit and calculate the bulk density by using formula (United 
States Pharmacopoaeia, 2003).
Unit of bulk density is gm/cm3 
DB=M/Vb
Where, M = weight of the sample and Vb =mean bulk volume of the 
sample.
2.2.2 Tapped density (D
T
)
Take a 100ml measuring cylinder and poured the screened sample at an angle 
of about 45o keep the measuring cylinder on a Stampfvolumeter and start 
tapping till no more changes occurs in volume and note the constant volume 





Where, M = weight of the sample and VT = tapped volume of the sample.
2.2.3 Carr’s index
The Carr’s index is the tendency of a powder to be compressed and it 






the theory, less compressible material is more flowable. Hence a free 
flowing powder has less significant interactions and therefore their 
values for bulk and tapped densities will be closer. Materials with poor 
flow have greater inter-particle interactions, and therefore their values 
for bulk and tapped densities will have greater difference (Khandelwal 
KR, 2009; Kokate CK, 2008). 
Compressibility index formula can calculate this difference 
  Compressibilityindex DT-DB
DT
= ×100  
 Where, DB = Bulk Density, DT = Tapped Density
2.2.4 Hausner’s ratio (HR) Compressibility index (CI)[33]
The Hausner ratio (HR) and Compressibility index (CI) of the samples can be 
determined by using the formula  
 HR = DT/DB  
Hausner’s ratio less than 1.25 shows better flow properties, between 1.25 to 
1.5 shows moderate flow properties and greater than 1.5 shows poor flow 
(Paronen P and Ikka J, 1995).
2.2.5 Angle of repose and Flow Rate
To determine angle of repose and flow rate the fixed-height cone technique 
was employed. Keep a glass funnel above a plane horizontal surface and fixed 
it at a 10 cm height by blocking its exit with a flat ruler. Spread a fresh white 
paper on the horizontal surface below the funnel for powder collection. Poured 
the specific weighed amount of sample into the funnel and unblock the exit of 
the funnel and by the help of a stop clock note the time required for the sample 
to totally flow out onto the paper. Measure the height and radius of the heap 
and calculate the flow rate and angle of repose (Carter SJ, 1986). 
Flow rate = M/t
Angle of repose = tan A = h/r
Where M = mass of the sample in grams, t = time taken for the sample to 
completely flow out of the funnel in seconds, A = angle (o) formed by the 







2.3 Evaluation of tablets 
2.3.1 Drug-Excipients Compatibility Study by FT-IR
FT-IR spectral analysis is used to detect any modification on chemical 
composition of the drug when it gets combined with the excipients 
Compatibility of the drug with excipients was determined by this study. The 
spectra of drug in KBr pellets are scanned between 4000-400 cm-1 in IR that 
shows the peak values for probable different functional group which will 
compare with standard value to determine the purity of sample (Margret C and 
Jayakar B, 2010).
2.3.2 Stability studies
Optimized drug formulation for determination of stability studies is 
subjected to different specified storage condition of temperature and relative 
humidity. 
For long term- 250C/60% RH for 12 months
For intermediate- 300C/60% RH for 6 months
For accelerated- 400C/75% RH for 3 months (ICH harmonised tripartite 
guideline stability testing of New drug substances and products, 2003)
2.3.3 Hardness and friability
Monsanto tablet hardness tester is used to determine hardness of tablet. 
Randomly select tablets to perform the test from each batch.   
Roche friabilator is used to determine in weight of previously weighed 
randomly selected twenty tablets for 4 min. at 25rpm. Remove the dust from 




= ×100  
2.3.4 Thickness
By the use of Vernier calipers thickness of tablet was determine. To perform 
the test 6 tablets are taken, and kept between two jaws of calipers and determine 
the thickness in mm.
2.3.5 Weight Variation
By using 1mg sensitivity balance, select 20 tablets randomly from every 








USP disintegration apparatus is used to perform disintegration test. Six tablets 
are taken, container filled with 900ml distilled water or buffer and maintained 
at 37±2°C. Note the time require to disintegrate all the tablets completely.
2.3.7 In vitro Dissolution test
USP dissolution test apparatus is used to perform dissolution test. Put two 
tablets in each of 6 dissolution vessels containing 900ml of distilled water 
or buffer solution maintained at 37 ± 0.2°C. Withdraw 10ml aliquots  at 
10, 20, 30, 40, 50 and 60 min time interval and filter them by the help of 
wattman filter paper. Put back equal amount of fresh dissolution medium after 
each withdrawal. This samples are then tested in UV spectrophotometer and 
determine the percentage drug release using a standard curve (Mishra S U 
et al, 2011).
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